Loading chat...
OH HB373
Bill
Status
11/9/2011
Primary Sponsor
Danny Bubp
Click for details
AI Summary
-
Establishes a state board of pharmacy list of opioid analgesic drugs with tamper-resistant technologies based on FDA approval and manufacturer evidence of tamper resistance properties
-
Prohibits pharmacists from substituting a different drug for a tamper-resistant opioid on the board's list unless the substitute has substantially similar tamper resistance properties or the prescriber provides written signed consent
-
Requires pharmacies to preserve all prescriptions and written consents related to opioid substitutions on file for three years, subject to inspection by law enforcement
-
Adds opioid analgesic drugs to existing restrictions on generic substitution, requiring board determination of substantially similar tamper resistance or prescriber consent before any substitution is allowed
-
Does not require tamper resistance claims on drug labeling for initial board list inclusion
Legislative Description
To prohibit a pharmacist from substituting another drug for a tamper resistant opioid analgesic drug unless the substituted drug is also tamper resistant or consent is obtained from the prescribing health professional.
Tamper resistant opioid analgesic drugs-restrict substitutions for
Last Action
To Health & Aging
11/9/2011